Published in J Mol Cell Cardiol on February 01, 2002
Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res (2013) 3.56
The immune system and cardiac repair. Pharmacol Res (2008) 3.42
Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest (2010) 3.09
Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol (2005) 2.60
Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol (2008) 2.60
Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med (2006) 2.23
Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A (2003) 2.21
Stem cell therapy is proarrhythmic. Circulation (2009) 1.83
Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J (2011) 1.80
Electrophysiological challenges of cell-based myocardial repair. Circulation (2009) 1.30
Cardiomyocytes fuse with surrounding noncardiomyocytes and reenter the cell cycle. J Cell Biol (2004) 1.26
Cardiac regeneration. Curr Top Dev Biol (2012) 1.17
Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease. Dis Model Mech (2009) 1.16
Human embryonic stem cells and cardiac repair. Transplant Rev (Orlando) (2008) 1.15
Cardiac tissue engineering for replacement therapy. Heart Fail Rev (2003) 1.09
beta(1)- and beta(2)-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart. Br J Pharmacol (2008) 1.07
Heart repair and stem cells. J Physiol (2006) 1.04
Cardiomyocyte formation by skeletal muscle-derived multi-myogenic stem cells after transplantation into infarcted myocardium. PLoS One (2008) 1.02
Cardiogenesis from human embryonic stem cells. Circ J (2010) 1.00
Cell-based therapy for heart disease: a clinically oriented perspective. Mol Ther (2009) 1.00
Stem cells for heart cell therapies. Tissue Eng Part B Rev (2008) 0.98
Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat. PLoS One (2008) 0.97
Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells. Stem Cell Res Ther (2011) 0.97
Challenges in identifying the best source of stem cells for cardiac regeneration therapy. Stem Cell Res Ther (2015) 0.95
Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis. J Mol Cell Cardiol (2008) 0.94
Angiomyogenesis for myocardial repair. Antioxid Redox Signal (2009) 0.93
Non-invasive analysis of myoblast transplants in rodent cardiac muscle. Int J Cardiovasc Imaging (2004) 0.93
Regenerating functional heart tissue for myocardial repair. Cell Mol Life Sci (2012) 0.92
Intrinsic ability of adult stem cell in skeletal muscle: an effective and replenishable resource to the establishment of pluripotent stem cells. Stem Cells Int (2013) 0.92
Stem cell therapy for pediatric dilated cardiomyopathy. Curr Cardiol Rep (2013) 0.91
Stem cell therapy: pieces of the puzzle. J Cardiovasc Transl Res (2009) 0.91
Human skeletal muscle cells with a slow adhesion rate after isolation and an enhanced stress resistance improve function of ischemic hearts. Mol Ther (2011) 0.90
Lessons for cardiac regeneration and repair through development. Trends Mol Med (2010) 0.89
MyoCell, a cell-based, autologous skeletal myoblast therapy for the treatment of cardiovascular diseases. Curr Opin Mol Ther (2008) 0.88
Functional and histopathological improvement of the post-infarcted rat heart upon myoblast cell grafting and relaxin therapy. J Cell Mol Med (2008) 0.87
Cardiac regeneration using pluripotent stem cells--progression to large animal models. Stem Cell Res (2014) 0.86
Nitric oxide-cyclic GMP signaling in stem cell differentiation. Free Radic Biol Med (2011) 0.85
Overexpression of connexin 43 using a retroviral vector improves electrical coupling of skeletal myoblasts with cardiac myocytes in vitro. BMC Cardiovasc Disord (2006) 0.84
Cell transplantation for cardiac regeneration: where do we stand? Neth Heart J (2008) 0.84
Pluripotent stem cells for cardiac regeneration: overview of recent advances & emerging trends. Indian J Med Res (2013) 0.82
Embryonic cardiomyocyte, but not autologous stem cell transplantation, restricts infarct expansion, enhances ventricular function, and improves long-term survival. PLoS One (2013) 0.81
Promises and pitfalls in cell replacement therapy for heart failure. Drug Discov Today Dis Mech (2010) 0.81
A G-CSF functionalized scaffold for stem cells seeding: a differentiating device for cardiac purposes. J Cell Mol Med (2010) 0.80
Cardiac Regeneration and Stem Cells. Physiol Rev (2015) 0.80
Lost in translation: what is limiting cardiomyoplasty and can tissue engineering help? Curr Stem Cell Res Ther (2009) 0.79
Increased angiogenesis and improved left ventricular function after transplantation of myoblasts lacking the MyoD gene into infarcted myocardium. PLoS One (2012) 0.78
Therapeutic potential of Pnmt+ primer cells for neuro/myocardial regeneration. Am J Stem Cells (2013) 0.77
Progenitor/stem cell transplantation for repair of myocardial infarction: Hype or hope? Ann Palliat Med (2012) 0.77
Does the human skeletal muscle harbor the murine equivalents of cardiac precursor cells? Mol Ther (2009) 0.77
"Second-generation" stem cells for cardiac repair. World J Stem Cells (2015) 0.77
Translational aspects of cardiac cell therapy. J Cell Mol Med (2015) 0.77
On the fate of skeletal myoblasts in a cardiac environment: down-regulation of voltage-gated ion channels. J Physiol (2004) 0.76
A device for separated and reversible co-culture of cardiomyocytes. Biotechnol Prog (2010) 0.76
Mending broken hearts one cell at a time. J Mol Cell Cardiol (2002) 0.76
Cellular replacement therapy for arrhythmia treatment: early clinical experience. J Interv Card Electrophysiol (2008) 0.76
Exogenous connexin43-expressing autologous skeletal myoblasts ameliorate mechanical function and electrical activity of the rabbit heart after experimental infarction. Int J Exp Pathol (2014) 0.75
Cellular Therapy for Heart Failure. Curr Cardiol Rev (2016) 0.75
Current Status and Perspectives in Stem Cell Therapy for Heart. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2014) 0.75
Intramyocardial cell delivery: observations in murine hearts. J Vis Exp (2014) 0.75
Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials. Anal Cell Pathol (Amst) (2017) 0.75
Cardiac repair--fact or fancy? Heart Fail Rev (2006) 0.75
Cellular cardiomyoplasty and cardiac regeneration. Curr Cardiol Rev (2008) 0.75
Comparison of arrhythmogenicity and proinflammatory activity induced by intramyocardial or epicardial myoblast sheet delivery in a rat model of ischemic heart failure. PLoS One (2015) 0.75
Combined biophysical and soluble factor modulation induces cardiomyocyte differentiation from human muscle derived stem cells. Sci Rep (2014) 0.75
Mouse adipose tissue stromal cells give rise to skeletal and cardiomyogenic cell sub-populations. Front Cell Dev Biol (2014) 0.75
Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol (2007) 14.48
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature (2004) 8.87
Truncations of titin causing dilated cardiomyopathy. N Engl J Med (2012) 6.07
Heart regeneration. Nature (2011) 5.91
Regenerating the heart. Nat Biotechnol (2005) 5.58
Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J (2007) 4.32
Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci U S A (2007) 3.90
Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature (2012) 3.63
Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res (2011) 3.25
A hierarchical network controls protein translation during murine embryonic stem cell self-renewal and differentiation. Cell Stem Cell (2008) 3.18
rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat Med (2006) 3.13
Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res (2002) 2.94
A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Cell (2012) 2.81
Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol (2005) 2.60
Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol (2008) 2.60
Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci U S A (2010) 2.58
Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Res (2014) 2.34
Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation (2005) 2.29
Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am J Pathol (2003) 2.22
Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS One (2010) 2.06
Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms. Annu Rev Pathol (2007) 1.86
Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. J Mol Cell Cardiol (2005) 1.78
Upregulation of cardiomyocyte ribonucleotide reductase increases intracellular 2 deoxy-ATP, contractility, and relaxation. J Mol Cell Cardiol (2011) 1.72
VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler Thromb Vasc Biol (2009) 1.57
Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function. Am J Pathol (2007) 1.43
Scaffold-free human cardiac tissue patch created from embryonic stem cells. Tissue Eng Part A (2009) 1.42
In vitro generation of differentiated cardiac myofibers on micropatterned laminin surfaces. J Biomed Mater Res (2002) 1.38
Bones of contention: marrow-derived cells in myocardial regeneration. J Mol Cell Cardiol (2008) 1.37
Evidence for fusion between cardiac and skeletal muscle cells. Circ Res (2004) 1.34
NFATc3-induced reductions in voltage-gated K+ currents after myocardial infarction. Circ Res (2004) 1.33
Myogenic fusion of human bone marrow stromal cells, but not hematopoietic cells. Blood (2004) 1.29
Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart. Stem Cells Dev (2013) 1.19
Myostatin represses physiological hypertrophy of the heart and excitation-contraction coupling. J Physiol (2009) 1.19
Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. J Biomed Mater Res A (2003) 1.19
Chromatin remodeling during mouse and human embryonic stem cell differentiation. Dev Dyn (2008) 1.18
Ferritin overexpression for noninvasive magnetic resonance imaging-based tracking of stem cells transplanted into the heart. Mol Imaging (2010) 1.16
Taking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biology. J Mol Cell Cardiol (2002) 1.16
Immunohistologic labeling of murine endothelium. Cardiovasc Pathol (2003) 1.15
Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Biomaterials (2010) 1.15
Measuring the contractile forces of human induced pluripotent stem cell-derived cardiomyocytes with arrays of microposts. J Biomech Eng (2014) 1.08
Human embryonic stem cells differentiated to lung lineage-specific cells ameliorate pulmonary fibrosis in a xenograft transplant mouse model. PLoS One (2012) 1.08
Cell therapy enhances function of remote non-infarcted myocardium. J Mol Cell Cardiol (2009) 1.07
Developing vasculature and stroma in engineered human myocardium. Tissue Eng Part A (2011) 1.07
Absence of regeneration in the MRL/MpJ mouse heart following infarction or cryoinjury. Cardiovasc Pathol (2007) 1.05
Cardiogenesis from human embryonic stem cells. Circ J (2010) 1.00
Targeted genomic integration of a selectable floxed dual fluorescence reporter in human embryonic stem cells. PLoS One (2012) 1.00
Gene transfer of connexin43 into skeletal muscle. Hum Gene Ther (2004) 0.99
Chemical dimerization of fibroblast growth factor receptor-1 induces myoblast proliferation, increases intracardiac graft size, and reduces ventricular dilation in infarcted hearts. Hum Gene Ther (2007) 0.96
Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts. J Cell Mol Med (2013) 0.96
Effects of cell grafting on coronary remodeling after myocardial infarction. J Am Heart Assoc (2013) 0.95
Cell grafting for cardiac repair. Methods Mol Biol (2003) 0.95
Is it possible to transform cardiac scar tissue into beating heart muscle in humans? Regen Med (2012) 0.94
Transmembrane protein 88: a Wnt regulatory protein that specifies cardiomyocyte development. Development (2013) 0.94
Monocyte chemoattractant protein 1-mediated migration of mesenchymal stem cells is a source of intimal hyperplasia. Arterioscler Thromb Vasc Biol (2013) 0.94
Comparison of Human Embryonic Stem Cell-Derived Cardiomyocytes, Cardiovascular Progenitors, and Bone Marrow Mononuclear Cells for Cardiac Repair. Stem Cell Reports (2015) 0.93
Heart regeneration with engineered myocardial tissue. Annu Rev Biomed Eng (2014) 0.93
Transgenic overexpression of ribonucleotide reductase improves cardiac performance. Proc Natl Acad Sci U S A (2013) 0.92
The role of macrophage-derived urokinase plasminogen activator in myocardial infarct repair: urokinase attenuates ventricular remodeling. J Mol Cell Cardiol (2010) 0.92
Nanotopography-Induced Structural Anisotropy and Sarcomere Development in Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells. ACS Appl Mater Interfaces (2016) 0.90
An improved cryosection method for polyethylene glycol hydrogels used in tissue engineering. Tissue Eng Part C Methods (2013) 0.89
Engineered human cardiac tissue. Pediatr Cardiol (2011) 0.89
Regenerative medicine: Reprogramming the injured heart. Nature (2012) 0.87
Quantification of MRI signal of transgenic grafts overexpressing ferritin in murine myocardial infarcts. NMR Biomed (2012) 0.86
Differentiation of cardiomyocytes from human embryonic stem cells is accompanied by changes in the extracellular matrix production of versican and hyaluronan. J Cell Biochem (2010) 0.86
Evidence that gene activation and silencing during stem cell differentiation requires a transcriptionally paused intermediate state. PLoS One (2011) 0.85
Thermoresponsive nanofabricated substratum for the engineering of three-dimensional tissues with layer-by-layer architectural control. ACS Nano (2014) 0.84
Lack of thrombospondin-2 reduces fibrosis and increases vascularity around cardiac cell grafts. Cardiovasc Pathol (2012) 0.83
Retention and biodistribution of microspheres injected into ischemic myocardium. J Biomed Mater Res A (2009) 0.81
Get with the (re)program: cardiovascular potential of skin-derived induced pluripotent stem cells. Circulation (2008) 0.81
Cardiopoietry in motion: primed mesenchymal stem cells for ischemic cardiomyopathy. J Am Coll Cardiol (2013) 0.81
Selective control of endothelial cell proliferation with a synthetic dimerizer of FGF receptor-1. Lab Invest (2007) 0.80
Retrograde perfusion and filling of mouse coronary vasculature as preparation for micro computed tomography imaging. J Vis Exp (2012) 0.80
Proangiogenic microtemplated fibrin scaffolds containing aprotinin promote improved wound healing responses. Angiogenesis (2013) 0.79
Synthetic matrices to serve as niches for muscle cell transplantation. Cells Tissues Organs (2011) 0.79
Cardiac aid to the injured but not the elderly? Nat Med (2007) 0.78
Skeletal muscle meets cardiac muscle. Friends or foes? J Am Coll Cardiol (2003) 0.77
A repair "kit" for the infarcted heart. Cell Stem Cell (2011) 0.77
New ISSCR guidelines: clinical translation of stem cell research. Lancet (2016) 0.77
Human myocardial grafts: do they meet all the criteria for true heart regeneration? Future Cardiol (2013) 0.76
Taking a load off: nuclear remodeling after mechanically supporting the failing human heart. Circulation (2010) 0.75
Trends in cardiovascular engineering: organizing the human heart. Trends Cardiovasc Med (2013) 0.75
Depth-resolved 3D visualization of coronary microvasculature with optical microangiography. Phys Med Biol (2016) 0.75
Micro- and nano-patterned conductive graphene-PEG hybrid scaffolds for cardiac tissue engineering. Chem Commun (Camb) (2017) 0.75
Intracoronary E-/L-selectin blockade reduces neutrophil infiltration in heart transplantation. Ann Thorac Surg (2002) 0.75
The advancement of human pluripotent stem cell-derived therapies into the clinic. Development (2015) 0.75